May 23, 2022

Researcher Update: May 2022

In this month’s Researcher Update you’ll find information on:

CURE Epilepsy Catalyst Award and Rare Epilepsy Partnership Award Call for Letters of Intent Opens May 31

Mark your calendars! The application process for the 2022 CURE Epilepsy Catalyst Award and the Rare Epilepsy Partnership Award is opening in just over a week!

The Catalyst Award (2 years, $250,000): This award is intended to stimulate and accelerate the development of new, transformative therapies for epilepsy, moving promising and well-supported preclinical and/or clinical research closer to clinical application.

The Rare Epilepsy Partnership Award (1 year, $100,000): This is a new award this year and will support the development of necessary research tools, techniques, model systems, and data collection platforms to stimulate and accelerate research on rare epilepsies. Each award will be co-funded by CURE Epilepsy and one or more rare epilepsy advocacy partners. The specific rare epilepsies to be studied with this award in 2022 will be identified in the Request for Proposals. Only research on the rare epilepsies identified in the RFP are eligible; applications must focus on one or more of the rare epilepsies identified.

Key dates for both awards:

Activity Approximate Date
Open Call for Letters of Intent Tuesday, May 31, 2022
Letter of Intent Deadline Wednesday, June 29, 2022, 9 PM ET
Full Proposal Invitations Friday, August 5, 2022
Full Proposals Due Tuesday, September 13, 2022, 9 PM ET
Awardee Notification December 2022-January 2023
Anticipated Award Start Date Spring 2023

Learn More

Announcing CURE Epilepsy’s 2021 Catalyst Award Grantees

We are delighted to announce our most recent grantees from the two CURE Epilepsy Catalyst Awards selected in 2021. Grantees Drs. James PaulyMatthew Gentry, and Greg Gerhardt from the University of Kentucky are advancing a potential new therapy for LaFora Disease, a devastating and progressive form of epilepsy. Dr. John Gledhill from Cognizance Biomarkers, LLC is researching potential blood-borne biomarkers that may predict response to antiseizure medications in people with newly diagnosed focal epilepsy. You can read more about their research awards here.

See Our Grantees

Applications for CURE Epilepsy’s 2022-2023 Research Seminar Series Are Being Accepted through May 27

We are currently accepting applications for our 2022-2023 Frontiers in Research Seminar Series supported by the Nussenbaum-Vogelstein Family. This series aims to help educate and expose young investigators to leading epilepsy research. CURE Epilepsy will provide $2,500 to each sponsored lectureship to offset costs associated with hosting a seminar at your institution. The deadline for applications is May 27, 2022, at 5 PM CST. A list of upcoming and past Frontiers in Research seminars is available here.

Learn More

CURE Epilepsy is a Proud Sponsor of These Upcoming Conferences

CURE Epilepsy sponsors conferences focused on communicating and advancing epilepsy research. Upcoming conferences include: International Conference for Technology and Analysis of Seizures (ICTALS)Gordon Research Conference (GRC) on Mechanisms of Epilepsy and Neuronal Synchronization, and the STXBP1 Summit+.

See All Conferences

Cures Within Reach – Request for Proposals

Cures Within Reach has released several funding opportunities for rare diseases as well as Diversity, Equity and Inclusion. Requested funding can cover costs of new projects or can supplement existing funding. The deadline for proposals is June 6.

Learn More

AES Annual Meeting 2022 Call for Abstract Submissions

The American Epilepsy Society has announced that abstract submission for the 2022 Annual Meeting in Nashville, TN is now open. Abstracts must be submitted by June 8 at 12pm (noon) PT for consideration.

Learn More

PAME Conference Call for Abstract Submissions

The sixth Partners Against Mortality in Epilepsy (PAME) Conference will take place Thursday, December 1, 2022 in conjunction with the AES Annual Meeting in Nashville, TN. This conference brings together healthcare providers, researchers, public health officials, patient advocates, caregivers, bereaved families, and people living with epilepsy. These diverse stakeholders come together with a shared goal of improving the understanding of mortality in epilepsy, including sudden unexpected death in epilepsy (SUDEP). PAME is collecting abstract submissions through the AES Annual Conference submission portal. Please check “I would like my abstract to be considered for PAME” on your submission form. The deadline for abstracts is June 8.

Submit Here


Related News